Literature DB >> 24567583

Increasing the QOF upper payment threshold in general practices in England: impact of implementing government proposals.

Michael Caley1, Samantha Burn, Tom Marshall, Andrew Rouse.   

Abstract

BACKGROUND: General practices in the UK receive incentive payments for managing patients with selected chronic conditions under the Quality and Outcomes Framework (QOF) scheme. Payments are made when a negotiated threshold percentage of patients receive the appropriate intervention. AIM: From 2013-2014 in England the Department of Health has proposed that this negotiated threshold is replaced with a value equal to the 75th percentile of national performance to attract maximum payments. This is an investigation of the potential impact of this change on practice income and workload. DESIGN AND
SETTING: Analysis of 2011-2012 QOF dataset (the latest available) which covers 8123 GP practices and 55.5 million patients in England.
METHOD: The 75th percentile of performance was calculated for 52 clinical indicators and applied to 2011-2012 performance. Estimations were made of financial and workload impacts on practices, and whether practices with different characteristics would be disproportionately affected.
RESULTS: The proposed changes will result in an increase in the upper payment threshold of each clinical indicator by a mean of 7.47% (range 2.16-38.87%). If performance remains static practices would lose a mean of 47.68 (0-108.33) QOF points, equivalent to a mean financial change of -£279.60 (-£35 352.50 to +£19 957.78) per practice for these 52 indicators.
CONCLUSION: Increasing the QOF upper payment threshold to the 75th percentile of national performance will, if clinical performance remains static, substantially reduce the mean number of QOF points achieved per practice. However, this translates into only a small mean loss of income per practice.

Entities:  

Keywords:  QOF; general practice; incentive; outcomes; payment

Mesh:

Year:  2014        PMID: 24567583      PMCID: PMC3876175          DOI: 10.3399/bjgp14X676465

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  14 in total

1.  Identifying unintended consequences of quality indicators: a qualitative study.

Authors:  Helen E Lester; Kerin L Hannon; Stephen M Campbell
Journal:  BMJ Qual Saf       Date:  2011-06-21       Impact factor: 7.035

2.  The UK pay-for-performance programme in primary care: estimation of population mortality reduction.

Authors:  Robert Fleetcroft; Sheetal Parekh-Bhurke; Amanda Howe; Richard Cookson; Louise Swift; Nicholas Steel
Journal:  Br J Gen Pract       Date:  2010-09       Impact factor: 5.386

3.  Patients' views of pay for performance in primary care: a qualitative study.

Authors:  Kerin L Hannon; Helen E Lester; Stephen M Campbell
Journal:  Br J Gen Pract       Date:  2012-05       Impact factor: 5.386

4.  Exception reporting in the Quality and Outcomes Framework: views of practice staff - a qualitative study.

Authors:  Stephen Campbell; Kerin Hannon; Helen Lester
Journal:  Br J Gen Pract       Date:  2011-04       Impact factor: 5.386

5.  Family doctor responses to changes in incentives for influenza immunization under the U.K. Quality and Outcomes Framework pay-for-performance scheme.

Authors:  Evangelos Kontopantelis; Tim Doran; Hugh Gravelle; Rosalind Goudie; Luigi Siciliani; Matt Sutton
Journal:  Health Serv Res       Date:  2011-12-15       Impact factor: 3.402

6.  The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators.

Authors:  Helen Lester; Julie Schmittdiel; Joe Selby; Bruce Fireman; Stephen Campbell; Janelle Lee; Alan Whippy; Philip Madvig
Journal:  BMJ       Date:  2010-05-11

7.  Quality of clinical primary care and targeted incentive payments: an observational study.

Authors:  Nicholas Steel; Susan Maisey; Allan Clark; Robert Fleetcroft; Amanda Howe
Journal:  Br J Gen Pract       Date:  2007-06       Impact factor: 5.386

8.  Pay-for-performance programs in family practices in the United Kingdom.

Authors:  Tim Doran; Catherine Fullwood; Hugh Gravelle; David Reeves; Evangelos Kontopantelis; Urara Hiroeh; Martin Roland
Journal:  N Engl J Med       Date:  2006-07-27       Impact factor: 91.245

9.  Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework.

Authors:  Tim Doran; Evangelos Kontopantelis; Jose M Valderas; Stephen Campbell; Martin Roland; Chris Salisbury; David Reeves
Journal:  BMJ       Date:  2011-06-28

10.  Recorded quality of primary care for patients with diabetes in England before and after the introduction of a financial incentive scheme: a longitudinal observational study.

Authors:  Evangelos Kontopantelis; David Reeves; Jose M Valderas; Stephen Campbell; Tim Doran
Journal:  BMJ Qual Saf       Date:  2012-08-22       Impact factor: 7.035

View more
  3 in total

Review 1.  Implementation Processes and Pay for Performance in Healthcare: A Systematic Review.

Authors:  Karli K Kondo; Cheryl L Damberg; Aaron Mendelson; Makalapua Motu'apuaka; Michele Freeman; Maya O'Neil; Rose Relevo; Allison Low; Devan Kansagara
Journal:  J Gen Intern Med       Date:  2016-04       Impact factor: 5.128

2.  The impact of removing financial incentives and/or audit and feedback on chlamydia testing in general practice: A cluster randomised controlled trial (ACCEPt-able).

Authors:  Jane S Hocking; Anna Wood; Meredith Temple-Smith; Sabine Braat; Matthew Law; Liliana Bulfone; Callum Jones; Mieke van Driel; Christopher K Fairley; Basil Donovan; Rebecca Guy; Nicola Low; John Kaldor; Jane Gunn
Journal:  PLoS Med       Date:  2022-01-04       Impact factor: 11.069

3.  Can preventive care activities in general practice be sustained when financial incentives and external audit plus feedback are removed? ACCEPt-able: a cluster randomised controlled trial protocol.

Authors:  Jane S Hocking; Meredith Temple-Smith; Mieke van Driel; Matthew Law; Rebecca Guy; Liliana Bulfone; Anna Wood; Nicola Low; Basil Donovan; Christopher K Fairley; John Kaldor; Jane Gunn
Journal:  Implement Sci       Date:  2016-09-13       Impact factor: 7.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.